• Login
  • Register & Subscribe
  • Language: EN FR DE

22 May 2013

2 hours 54 min ago
MedNous
  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Oropharyngeal candidiasis

For BioAlliance Pharma delivery is innovation

Saturday 5 September 2009

Interviewee/Contributer: Dominique Costantini

Organisation: BioAlliance Pharma SA

Full text available to subscribers only. Click here for information on subscribing to MedNous.

  • Drug delivery
  • Mucoadhesive delivery
  • Nanoparticle delivery
  • Oropharyngeal candidiasis
  • 1 attachment
Syndicate content

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Pascale Witz to head strategic development at Sanofi

Monday May 6 2013

Srinivas Akkaraju joins Sofinnova Ventures

Monday May 6 2013

Vicente Anido nominated to Nicox board

Monday May 6 2013

Jeremy Farrar named director of the Wellcome Trust

Monday May 6 2013

Harry Kirsch becomes CFO at Novartis

Monday May 6 2013

© 2013 Evernow Publishing Ltd

Site by Five Mile, powered by Drupal.